News
FDA Approves Avastin Biosimilar Agent, Jobevne
- Author:
- Sharon Worcester, MA
Publish date: April 15, 2025
News
FDA OKs First-line Nivolumab + Ipilimumab in Advanced HCC
- Author:
- Sharon Worcester, MA
Publish date: April 15, 2025
News
Assay Shows Promise for Early-Stage Melanoma Risk Assessment Beyond SNLB
- Author:
- Sharon Worcester, MA
Publish date: April 8, 2025
News
FDA Approves Pluvicto for Earlier Use in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
- Author:
- Sharon Worcester, MA
Publish date: April 1, 2025
News
New Cancer Vaccines on the Horizon: Renewed Hope or Hype?
- Author:
- Sharon Worcester, MA
Publish date: December 6, 2024
News
FDA Approves Bizengri for NSCLC and Pancreatic Cancers Harboring NRG1 Gene Fusion
- Author:
- Sharon Worcester, MA
Publish date: December 5, 2024
News
FDA Approves Obe-cel, a Novel CD19 CAR T Product for ALL
- Author:
- Sharon Worcester, MA
Publish date: November 11, 2024
News
Cannabis in Cancer: What Oncologists and Patients Should Know
- Author:
- Sharon Worcester, MA
Publish date: October 23, 2024
News
Gotistobart Trial for NSCLC on Partial Clinical Hold
- Author:
- Sharon Worcester, MA
Publish date: October 23, 2024
News
ACS: Breast Cancer Incidence Rising, Mortality Disparities Persist
- Author:
- Sharon Worcester, MA
Publish date: October 9, 2024
News
Isatuximab Quadruplet Approval Could Change the Landscape for Treating Myeloma
- Author:
- Sharon Worcester, MA
Publish date: October 7, 2024
News
MM: First CAR T-Cell Therapy to Exhibit OS Benefit
- Author:
- Sharon Worcester, MA
Publish date: October 3, 2024
News
FDA Okays Osimertinib After CRT in Locally Advanced, Unresectable NSCLC
- Author:
- Sharon Worcester, MA
Publish date: September 27, 2024
News
AACR Cancer Progress Report: Big Strides and Big Gaps
- Author:
- Sharon Worcester, MA
Publish date: September 26, 2024
News
FDA OKs Subcutaneous Atezolizumab Formulation for Multiple Cancer Indications
- Author:
- Sharon Worcester, MA
Publish date: September 17, 2024